Tigem
Paolo Grumati has extensive experience in the field of genetic and molecular biology, currently serving as an RTDB at Università degli Studi di Napoli Federico II since October 2021 and as a Principal Investigator at Tigem since January 2019. Previous roles include a Post-Doctoral position at Goethe University from September 2013 to December 2018 and another Post-Doctoral position at the University of Padova from January 2009 to August 2013. Paolo Grumati earned a Doctor of Philosophy (PhD) in Genetic and Molecular Biology from Università degli Studi di Padova between 2006 and 2009, following a Master’s Degree in Medical Biotechnologies at the same institution from 1999 to 2005.
This person is not in any teams
This person is not in any offices
Tigem
The Telethon Institute of Genetics and Medicine (TIGEM) is a multidisciplinary research Institute devoted to studying the mechanisms underlying rare genetic diseases and to developing innovative therapies. With the support of Fondazione Telethon, the European Community and many other funding agencies, TIGEM's research groups are engaged in numerous clinical trials and collaborative projects. In addition, TIGEM's alliances with various universities offer the Institute additional resources and provide opportunities for excellent students. TIGEM is a Telethon Foundation research centre in Pozzuoli, Italy. TIGEM comprises several research groups and over 200 staff members, all dedicated to understanding the molecular mechanisms behind rare genetic diseases and developing novel treatments. These diseases, often overlooked by pharmaceutical industries, are most common in children and adolescents. TIGEM’s research falls into three main themes: Cell Biology and Disease Mechanisms, Genomic Medicine, and Molecular Therapy. Our research is supported by a number of in-house highly specialised facilities, as well as significant international support in the form of funding and collaborative opportunities.